0000899243-22-012514.txt : 20220328
0000899243-22-012514.hdr.sgml : 20220328
20220328183958
ACCESSION NUMBER: 0000899243-22-012514
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220328
DATE AS OF CHANGE: 20220328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibbs Michael Terrence
CENTRAL INDEX KEY: 0001665000
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22776821
MAIL ADDRESS:
STREET 1: 12 STONEY BROOK RD.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-02-24
2022-02-28
0
0001492674
T2 Biosystems, Inc.
TTOO
0001665000
Gibbs Michael Terrence
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
General Counsel
Common Stock
2022-02-24
4
M
0
145719
A
225642
D
Common Stock
2022-02-24
4
F
0
76867
0.4488
D
148775
D
Restricted Stock Units
2022-02-24
4
M
0
145719
0.00
D
Common Stock
145719
291439
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 215,642.
76,867 shares of common stock were automatically withheld at vesting to cover required tax withholding.
The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 138,775.
On February 24, 2021 the reporting person was granted 437,158 RSU's that vest in three equal annual installments commencing on February 24, 2022.
/s/ John Sprague, Attorney-in-fact
2022-03-28